At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Marketed Contact Lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of An Approved Contact Lens
In Brief
A clinical study evaluating Marketed Contact Lens for Tear Film Characteristics. Completed, enrolled 31 participants across 1 site.
Detailed Summary
This is an 8-visit, bilateral, dispensing clinical study to evaluate the change in tear fluid pH and tear film osmolarity in an FDA-cleared contact lens in new contact lens users over a 14-day period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTear Film Characteristics
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartApr 2016
Primary CompletionApr 2016
First PostedMay 2016
TodayJul 2026
First PostedMay 4, 2016
Enrollment StartApr 12, 2016
Primary CompletionApr 26, 2016
TodayJul 2, 2026
Enrollment to primary: 14 daysPosted 10.2 years ago
Interventions
Marketed Contact Lensdevice
Narafilcon A